| RS45517413 |
TSC2
|
Health Risk |
Likely pathogenic |
Tuberous sclerosis syndrome, Tuberous sclerosis syndrome |
| RS45517414 |
TSC2
|
Health Risk |
Conflicting classifications of pathogenicity |
Tuberous sclerosis syndrome, Tuberous sclerosis 2 |
| RS45517418 |
TSC2
|
Health Risk |
Conflicting classifications of pathogenicity |
Tuberous sclerosis 2, Hereditary cancer-predisposing syndrome |
| RS45517419 |
TSC2
|
Health Risk |
Conflicting classifications of pathogenicity |
Tuberous sclerosis syndrome, Hereditary cancer-predisposing syndrome |
| RS45517420 |
TSC2
|
Health Risk |
Conflicting classifications of pathogenicity |
Tuberous sclerosis 2, Hereditary cancer-predisposing syndrome |
| RS45517932 |
PKHD1
|
Health Risk |
Conflicting classifications of pathogenicity |
Autosomal recessive polycystic kidney disease, Polycystic kidney disease 4 |
| RS45519531 |
CIITA
|
Health Risk |
Conflicting classifications of pathogenicity |
MHC class II deficiency, MHC class II deficiency |
| RS45519733 |
SLC4A1
|
Health Risk |
Likely pathogenic |
Autosomal dominant distal renal tubular acidosis, Autosomal dominant distal renal tubular acidosis |
| RS45520032 |
TNNT2
|
Health Risk |
Conflicting classifications of pathogenicity |
Hypertrophic cardiomyopathy 2, Dilated cardiomyopathy 1D |
| RS45520237 |
MET
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Renal cell carcinoma |
| RS45521338 |
LDB3
|
Health Risk |
Conflicting classifications of pathogenicity |
Myofibrillar myopathy 4, Cardiovascular phenotype |
| RS45522138 |
SCN5A
|
Health Risk |
Conflicting classifications of pathogenicity |
Cardiovascular phenotype, Long QT syndrome 3 |
| RS45522236 |
PDE6C
|
Health Risk |
Conflicting classifications of pathogenicity |
Cone dystrophy 4, Achromatopsia |
| RS45522532 |
CDH23
|
Health Risk |
Conflicting classifications of pathogenicity |
Autosomal recessive nonsyndromic hearing loss 12, Usher syndrome type 1D |
| RS45523233 |
MYH7
|
Health Risk |
Conflicting classifications of pathogenicity |
MYH7-related skeletal myopathy, Hypertrophic cardiomyopathy |
| RS45524433 |
UCP2
|
Health Risk |
Conflicting classifications of pathogenicity |
UCP2-related disorder, UCP2-related disorder |
| RS45524646 |
FANCE
|
Health Risk |
Conflicting classifications of pathogenicity |
Fanconi anemia complementation group E, Fanconi anemia complementation group E |
| RS45525839 |
TNNT2
|
Health Risk |
Conflicting classifications of pathogenicity |
Primary dilated cardiomyopathy, Dilated cardiomyopathy 1D |
| RS45526732 |
IL10RB
|
Health Risk |
Conflicting classifications of pathogenicity |
Inflammatory bowel disease 25, Inflammatory bowel disease 25 |
| RS45527543 |
WHRN
|
Health Risk |
Conflicting classifications of pathogenicity |
Retinitis pigmentosa-deafness syndrome, Autosomal recessive nonsyndromic hearing loss 31 |
| RS45528833 |
BRIP1
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Familial cancer of breast |
| RS45531732 |
SLC5A5
|
Health Risk |
Conflicting classifications of pathogenicity |
Thyroid dyshormonogenesis 1, Thyroid dyshormonogenesis 1 |
| RS45532440 |
PALB2
|
Health Risk |
Pathogenic |
Familial cancer of breast, Familial cancer of breast |
| RS45532739 |
TNNI3K
|
Health Risk |
Conflicting classifications of pathogenicity |
TNNI3K-related disorder, Atrial conduction disease |
| RS45533636 |
BRIP1
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Familial cancer of breast |
| RS45535636 |
WEE2
|
Health Risk |
Conflicting classifications of pathogenicity |
WEE2-related disorder, WEE2-related disorder |
| RS45537237 |
PALB2
|
Health Risk |
Conflicting classifications of pathogenicity |
Familial cancer of breast, Hereditary cancer-predisposing syndrome |
| RS45538536 |
TH
|
Health Risk |
Conflicting classifications of pathogenicity |
Autosomal recessive DOPA responsive dystonia, Autosomal recessive DOPA responsive dystonia |
| RS45539432 |
PINK1
|
Health Risk |
Pathogenic |
Autosomal recessive early-onset Parkinson disease 6, PINK1-related disorder |
| RS45539535 |
LDB3
|
Health Risk |
Conflicting classifications of pathogenicity |
Cardiovascular phenotype, Cardiomyopathy |
| RS45539936 |
CTSC
|
Health Risk |
Conflicting classifications of pathogenicity |
Papillon-Lefèvre syndrome, Haim-Munk syndrome |
| RS45540031 |
MCPH1
|
Health Risk |
Conflicting classifications of pathogenicity |
Microcephaly 1, primary |
| RS45540732 |
TCAP
|
Health Risk |
Conflicting classifications of pathogenicity |
Hypertrophic cardiomyopathy 25, Autosomal recessive limb-girdle muscular dystrophy type 2G |
| RS45543843 |
PALB2
|
Health Risk |
Conflicting classifications of pathogenicity |
Familial cancer of breast, Hereditary cancer-predisposing syndrome |
| RS45544633 |
MYH7
|
Health Risk |
Pathogenic/Likely pathogenic |
Primary dilated cardiomyopathy, Hypertrophic cardiomyopathy |
| RS45545138 |
IL10RB
|
Health Risk |
Conflicting classifications of pathogenicity |
Inflammatory bowel disease 25, IL10RB-related disorder |
| RS45546039 |
SCN5A
|
Health Risk |
Pathogenic |
Dilated cardiomyopathy 1E, Congenital long QT syndrome |
| RS45547231 |
RAPSN
|
Health Risk |
Conflicting classifications of pathogenicity |
Congenital myasthenic syndrome 11, Fetal akinesia deformation sequence 1 |
| RS45548237 |
SCN5A
|
Health Risk |
Conflicting classifications of pathogenicity |
Long QT syndrome, Cardiovascular phenotype |
| RS45548638 |
PALB2
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Familial cancer of breast |
| RS45549044 |
USH2A
|
Health Risk |
Conflicting classifications of pathogenicity |
Usher syndrome type 2A, Retinitis pigmentosa 39 |
| RS45549246 |
SIX6
|
Health Risk |
Conflicting classifications of pathogenicity |
Colobomatous optic disc-macular atrophy-chorioretinopathy syndrome, Anophthalmia-microphthalmia syndrome |
| RS45549534 |
DMD
|
Health Risk |
Conflicting classifications of pathogenicity |
Dilated cardiomyopathy 3B, Dilated cardiomyopathy 3B |
| RS45550635 |
CSRP3
|
Health Risk |
Conflicting classifications of pathogenicity |
Dilated cardiomyopathy 1M, Primary dilated cardiomyopathy |
| RS45551636 |
PALB2
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Familial cancer of breast |
| RS45553235 |
SCN5A
|
Health Risk |
Conflicting classifications of pathogenicity |
Long QT syndrome, Brugada syndrome |
| RS45553236 |
MET
|
Health Risk |
Conflicting classifications of pathogenicity |
Renal cell carcinoma, Hereditary cancer-predisposing syndrome |
| RS45553935 |
BRCA1
|
Health Risk |
Pathogenic/Likely pathogenic |
Breast-ovarian cancer, familial |
| RS45555435 |
USH2A
|
Health Risk |
Likely pathogenic |
Usher syndrome type 2, Usher syndrome type 2 |
| RS45555831 |
BRCA2
|
Health Risk |
Pathogenic |
Breast-ovarian cancer, familial |
| RS45559331 |
UBQLN2
|
Health Risk |
Conflicting classifications of pathogenicity |
Amyotrophic lateral sclerosis type 15, Amyotrophic lateral sclerosis type 15 |
| RS45559338 |
PCK1
|
Health Risk |
Conflicting classifications of pathogenicity |
Phosphoenolpyruvate carboxykinase deficiency, cytosolic |
| RS45560242 |
MYH7
|
Health Risk |
Conflicting classifications of pathogenicity |
MYH7-related skeletal myopathy, Hypertrophic cardiomyopathy |
| RS45561331 |
PALB2
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Familial cancer of breast |
| RS45562031 |
SLC4A1
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary spherocytosis type 4, Hemolytic anemia |
| RS45562835 |
XDH
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary xanthinuria type 1, Xanthinuria type II |
| RS45563431 |
TNFRSF1A
|
Health Risk |
Conflicting classifications of pathogenicity |
TNF receptor-associated periodic fever syndrome (TRAPS), TNF receptor-associated periodic fever syndrome (TRAPS) |
| RS45563436 |
ADGRE2
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS45563942 |
SCN5A
|
Health Risk |
Conflicting classifications of pathogenicity |
Dilated cardiomyopathy 1E, Primary dilated cardiomyopathy |
| RS45564238 |
BRCA1
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Breast-ovarian cancer |
| RS45564937 |
MET
|
Health Risk |
Conflicting classifications of pathogenicity |
Papillary renal cell carcinoma type 1, Hereditary cancer-predisposing syndrome |
| RS45565337 |
MYH7
|
Health Risk |
Conflicting classifications of pathogenicity |
Hypertrophic cardiomyopathy, Cardiomyopathy |
| RS45566639 |
MYH7
|
Health Risk |
Conflicting classifications of pathogenicity |
MYH7-related skeletal myopathy, Hypertrophic cardiomyopathy 1 |
| RS45566933 |
GAD1
|
Health Risk |
Conflicting classifications of pathogenicity |
Neurodevelopmental disorder with progressive spasticity and brain white matter abnormalities, Inborn genetic diseases |
| RS45566938 |
BRIP1
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Fanconi anemia complementation group J |
| RS45567240 |
PEX26
|
Health Risk |
Conflicting classifications of pathogenicity |
Peroxisome biogenesis disorder 7A (Zellweger), Peroxisome biogenesis disorder 7B |
| RS45568335 |
ABCD4
|
Health Risk |
Conflicting classifications of pathogenicity |
Methylmalonic acidemia with homocystinuria, type cblJ |
| RS45568837 |
SLC4A1
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS45570339 |
ANK2
|
Health Risk |
Conflicting classifications of pathogenicity |
Congenital long QT syndrome, Long QT syndrome |
| RS45570735 |
TP53RK
|
Health Risk |
Conflicting classifications of pathogenicity |
Galloway-Mowat syndrome 4, Galloway-Mowat syndrome 4 |
| RS45572934 |
BRIP1
|
Health Risk |
Likely pathogenic |
Hereditary cancer-predisposing syndrome, Familial cancer of breast |
| RS45572939 |
F7
|
Health Risk |
Conflicting classifications of pathogenicity |
Factor VII deficiency, Factor VII deficiency |
| RS45573835 |
CHD7
|
Health Risk |
Conflicting classifications of pathogenicity |
Hypogonadotropic hypogonadism 5 with or without anosmia, Hypogonadotropic hypogonadism 5 with or without anosmia |
| RS45574039 |
PTCH1
|
Health Risk |
Conflicting classifications of pathogenicity |
Gorlin syndrome, Hereditary cancer-predisposing syndrome |
| RS45574335 |
CUL7
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS45575636 |
ABCB4
|
Health Risk |
Conflicting classifications of pathogenicity |
Cholestasis, intrahepatic |
| RS45576136 |
MAN2B1
|
Health Risk |
Conflicting classifications of pathogenicity |
Deficiency of alpha-mannosidase, MAN2B1-related disorder |
| RS45577134 |
LDB3
|
Health Risk |
Conflicting classifications of pathogenicity |
Myofibrillar myopathy 4, Cardiovascular phenotype |
| RS45577338 |
XDH
|
Health Risk |
Conflicting classifications of pathogenicity |
Xanthinuria type II, Hereditary xanthinuria type 1 |
| RS45578238 |
TNNT2
|
Health Risk |
Pathogenic/Likely pathogenic |
Dilated cardiomyopathy 1D, Primary dilated cardiomyopathy |
| RS45579032 |
PTCH1
|
Health Risk |
Conflicting classifications of pathogenicity |
Gorlin syndrome, Hereditary cancer-predisposing syndrome |
| RS45579739 |
POMT2
|
Health Risk |
Conflicting classifications of pathogenicity |
Autosomal recessive limb-girdle muscular dystrophy type 2N, Autosomal recessive limb-girdle muscular dystrophy type 2N |
| RS45580035 |
BRCA2
|
Health Risk |
Pathogenic |
Hereditary breast ovarian cancer syndrome, Breast-ovarian cancer |
| RS45581435 |
LDB3
|
Health Risk |
Pathogenic |
Myofibrillar myopathy 4, Myofibrillar myopathy 4 |
| RS45585831 |
MET
|
Health Risk |
Conflicting classifications of pathogenicity |
Papillary renal cell carcinoma type 1, Hereditary cancer-predisposing syndrome |
| RS45585833 |
PALB2
|
Health Risk |
Conflicting classifications of pathogenicity |
Familial cancer of breast, Hereditary cancer-predisposing syndrome |
| RS45586239 |
MET
|
Health Risk |
Conflicting classifications of pathogenicity |
Renal cell carcinoma, Hereditary cancer-predisposing syndrome |
| RS45586240 |
TNNT2
|
Health Risk |
Conflicting classifications of pathogenicity |
Primary dilated cardiomyopathy, Cardiovascular phenotype |
| RS45587542 |
PIK3AP1
|
Health Risk |
Conflicting classifications of pathogenicity |
Infantile spasms, Infantile spasms |
| RS45587735 |
SCN5A
|
Health Risk |
Conflicting classifications of pathogenicity |
Cardiac arrhythmia, Cardiac arrhythmia |
| RS45587940 |
MET
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Renal cell carcinoma |
| RS45588036 |
GHR
|
Health Risk |
Conflicting classifications of pathogenicity |
Short stature due to partial GHR deficiency, Short stature due to partial GHR deficiency |
| RS45588436 |
CHRNA4
|
Health Risk |
Conflicting classifications of pathogenicity |
Autosomal dominant nocturnal frontal lobe epilepsy, Inborn genetic diseases |
| RS45589337 |
DPYD
|
Health Risk |
Conflicting classifications of pathogenicity |
Dihydropyrimidine dehydrogenase deficiency, Inborn genetic diseases |
| RS45589637 |
BRIP1
|
Health Risk |
Conflicting classifications of pathogenicity |
Fanconi anemia complementation group J, Familial cancer of breast |
| RS45590135 |
SYNE2
|
Health Risk |
Conflicting classifications of pathogenicity |
Emery-Dreifuss muscular dystrophy 5, autosomal dominant |
| RS45592142 |
XRCC1
|
Health Risk |
association |
Laryngeal squamous cell carcinoma, Laryngeal squamous cell carcinoma |
| RS45592239 |
ABCA3
|
Health Risk |
Conflicting classifications of pathogenicity |
Interstitial lung disease due to ABCA3 deficiency, Hereditary pulmonary alveolar proteinosis |
| RS45592846 |
MET
|
Health Risk |
Conflicting classifications of pathogenicity |
Renal cell carcinoma, Hereditary cancer-predisposing syndrome |
| RS45592941 |
TCAP
|
Health Risk |
Conflicting classifications of pathogenicity |
Hypertrophic cardiomyopathy 25, Autosomal recessive limb-girdle muscular dystrophy type 2G |